Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating safety, tolerability, and pharmacokinetics of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Etelcalcetide (etelcalcetide)

Snippet

Sponsor: KAI Pharmaceuticals | Conditions: Hyperparathyroidism, Secondary | Phase 1 | Status: COMPLETED | Results posted: 2018-01-02